Application 209312
- Type
- ANDA
- Sponsor
- GRANULES INDIA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | METHOCARBAMOL | METHOCARBAMOL | TABLET;ORAL | 500MG | No | Yes |
| 002 | METHOCARBAMOL | METHOCARBAMOL | TABLET;ORAL | 750MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209312-001 | METHOCARBAMOL | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 |
| A209312-002 | METHOCARBAMOL | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209312-001 | AA |
| A209312-002 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209312-001 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209312-002 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 52b20439-6bf4-435e-817a-c3b3fc70846a | 2026-07-10 | Warnings, Adverse reactions | 209312 ANDA209312 70518-1723 |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 37767123-8b72-4e1f-b00d-ff3305e9923f | 2026-07-10 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Unit Dose Solutions, Inc. | 561ae476-9e1f-038a-e063-6394a90aa5c7 | 2026-07-08 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Granules Pharmaceuticals Inc. | 6f0d3966-962d-fa7c-e053-2a91aa0a8e3c | 2026-07-07 | Warnings, Adverse reactions | 209312 ANDA209312 70010-770 70010-754 |
| Methocarbamol | METHOCARBAMOL TABLETS | Bryant Ranch Prepack | 65c460f6-6470-41ff-abb4-d9d54ecc52f7 | 2026-07-06 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | St. Mary's Medical Park Pharmacy | 7d4dd78a-f902-6ff2-e053-2991aa0ac7d7 | 2026-06-26 | Warnings, Adverse reactions | 209312 ANDA209312 60760-770 |
| Methocarbamol | METHOCARBAMOL TABLETS | Preferred Pharmaceuticals Inc. | 43f83b87-e169-46fe-98bd-6af373595bd3 | 2026-06-23 | Warnings, Adverse reactions | 209312 ANDA209312 68788-8172 |
| Methocarbamol | METHOCARBAMOL TABLETS | Preferred Pharmaceuticals Inc. | e03878d3-d780-4e7f-b828-20ac2a109933 | 2026-06-23 | Warnings, Adverse reactions | 209312 ANDA209312 68788-8213 |
| Methocarbamol | METHOCARBAMOL TABLETS | Coupler LLC | 52b87514-e6e0-ab57-e063-6394a90a6b23 | 2026-05-26 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 71c21226-cd96-33ed-e053-2995a90a5269 | 2026-05-22 | Warnings, Adverse reactions | 209312 ANDA209312 68071-4505 |
| Methocarbamol | METHOCARBAMOL TABLETS | St. Mary's Medical Park Pharmacy | faa81ad3-2bd2-d637-e053-6294a90a2d36 | 2026-05-10 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Proficient Rx LP | 23163bc1-dec7-41f6-baed-eedebfd6be7e | 2026-05-01 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 1dc3a5b1-c83b-406b-a59d-ce8075e4ccf9 | 2026-04-28 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Advanced Rx of Tennessee, LLC | 4de118fe-bd8e-6cc4-e063-6394a90a1320 | 2026-03-25 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Advanced Rx of Tennessee, LLC | 4cefe51c-d824-a862-e063-6394a90a7717 | 2026-03-13 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Redpharm Drug | 44f264fd-bf40-bed9-e063-6294a90ac44a | 2026-03-05 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 72f36d28-15d2-30f6-e053-2a91aa0ad1ce | 2026-01-30 | Warnings, Adverse reactions | 209312 ANDA209312 68071-4520 |
| Methocarbamol | METHOCARBAMOL TABLETS | Northwind Health Company, LLC | f2b4ed95-0469-393a-e053-2a95a90a98ed | 2026-01-19 | Warnings, Adverse reactions | 209312 ANDA209312 |
| METHOCARBAMOL | METHOCARBAMOL | DIRECT RX | 31508051-c9cb-149b-e054-00144ff88e88 | 2026-01-08 | Warnings, Adverse reactions | 209312 ANDA209312 61919-616 |
| Methocarbamol | METHOCARBAMOL TABLETS | Northwind Health Company, LLC | f2b4ed5f-3489-9ee4-e053-2995a90a25f0 | 2026-01-01 | Warnings, Adverse reactions | 209312 ANDA209312 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 35573-413 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-413 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-413 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-413 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-414 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-414 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-414 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 35573-414 | Methocarbamol | Methocarbamol | Burel Pharmaceuticals, Inc. | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, In | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-903 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-905 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, In | ANDA | Current |
| 43063-905 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-905 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-905 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-905 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-905 | Methocarbamol | Methocarbamol Tablets | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 50090-3556 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3556 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3556 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3557 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3557 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3557 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3570 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3570 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50090-3570 | Methocarbamol | Methocarbamol Tablets | A-S Medication Solutions | ANDA | Current |
| 50436-0770 | Methocarbamol | Methocarbamol Tablets | Unit Dose Services | ANDA | Current |
| 53002-3591 | Methocarbamol | Methocarbamol Tablets | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 60760-770 | Methocarbamol | Methocarbamol Tablets | St. Mary's Medical Park Pharmacy | ANDA | Current |
| 60760-770 | Methocarbamol | Methocarbamol Tablets | St. Mary's Medical Park Pharmacy | ANDA | Current |
| 60760-770 | Methocarbamol | Methocarbamol Tablets | St. Mary's Medical Park Pharmacy | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | DirectRX | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | DirectRX | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-610 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | Direct_Rx | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 61919-616 | Methocarbamol | Methocarbamol | DIRECT RX | ANDA | Current |
| 62207-754 | Methocarbamol | Methocarbamol Tablets | Granules India Ltd | ANDA | Current |
| 62207-754 | Methocarbamol | Methocarbamol Tablets | Granules India Ltd | ANDA | Current |
| 62207-754 | Methocarbamol | Methocarbamol Tablets | Granules India Ltd | ANDA | Current |
| 62207-770 | Methocarbamol | Methocarbamol Tablets | Granules India Ltd | ANDA | Current |
| 62207-770 | Methocarbamol | Methocarbamol Tablets | Granules India Ltd | ANDA | Current |
| 62207-770 | Methocarbamol | Methocarbamol Tablets | Granules India Ltd | ANDA | Current |
| 63739-991 | Methocarbamol | Methocarbamol Tablets | McKesson Corporation dba SKY Packaging | ANDA | Current |
| 63739-992 | Methocarbamol | Methocarbamol Tablets | McKesson Corporation dba SKY Packaging | ANDA | Current |
| 67046-538 | Methocarbamol | Methocarbamol Tablets | Contract Pharmacy Services-PA | ANDA | Current |
| 68071-2867 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4505 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4505 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4505 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4505 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4520 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4520 | Methocarbamol | Methocarbamol Tablets | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68788-8172 | Methocarbamol | Methocarbamol Tablets | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-8213 | Methocarbamol | Methocarbamol Tablets | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 70010-754 | Methocarbamol | Methocarbamol Tablets | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-754 | Methocarbamol | Methocarbamol Tablets | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-754 | Methocarbamol | Methocarbamol Tablets | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-770 | Methocarbamol | Methocarbamol Tablets | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-770 | Methocarbamol | Methocarbamol Tablets | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70010-770 | Methocarbamol | Methocarbamol Tablets | Granules Pharmaceuticals Inc. | ANDA | Current |
| 70518-1723 | Methocarbamol | Methocarbamol Tablets | REMEDYREPACK INC. | ANDA | Current |